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(BSA) (Sigma) was treated with charcoal to remove fatty acids and 
Abstract Rat osteoblasts produce insulin-like growth factors steroid hormones. Guinea pig anti-serum raised against human 
(IGFs) and IGF binding proteins (IGFBPs). Expression of IGFBP-5 was a generous gift from D.R. Clemmons, University of 
IGFBP-5, an IGFBP which stimulates DNA synthesis of North Carolina (Chapel Hill, NC)[13]. 
osteoblasts, was studied in vitro under the influence of hz,25- 
dihydroxyvitamin D3 (1,25(OH)2D3) and parathyroid hormone 2.2. Cell culture 
(PTH). These two calcium-regulating hormones timulated the Osteoblast-like c lls were prepared from calvaria of newborn rats 
expression of IGFBP-5 mRNA in cultured rat osteoblasts at low by sequential digestion with collagenase (CLS II, Worthington) [6]. 
concentrations (10 pM) and in a dose- and time-dependent Primary cell cultures were trypsinized and 106 cells were plated per 10 
manner. Intact IGFBP-5 was not detected in the culture medium, cm diameter (55 cm 2 surface) dishes in phenol red-free c~-modified 
but was found attached to the cell layer. IGFBP-5 may thus minimum essential medium and Ham's F-12 medium (1:1 mixture, 
both from Gibco, Paisley, UK) containing fetal calf serum (FCS, 
direct IGFs to the sites of bone remodeling. 2%), 2 mM glutamine and 50 gg/ml of gentamycin. On the following 
day, cells were rinsed and fresh medium was added as above, except 
Key words: 1,25-Dihydroxyvitamin D3; that FCS was reduced to 1%. 2 days later, cells were rinsed and media 
Parathyroid hormone; Insulin-like growth factor I; replaced by phenol red-free c~-modified minimum essential medium 
Insulin-like growth factor binding protein-5; and Ham's F-12 medium (1:1 mixture) containing 0.2 g/1 of BSA, 
Insulin-like growth factor binding protein-3 2 mM glutamine, and 50 gg/ml of gentamycin for 2 × 2 days prior 
to test incubations as indicated. 
2.3. Processing of culture media, blot analysis for IGFBPs and 
radioimmunoassay for IGF I 
1. Introduction At the end of test periods, the conditioned media (10 ml) were 
collected, dialyzed against 0.1 M ammonium bicarbonate, lyophilized 
Insulin-like growth factors (IGFs) favor replication, differ- and dissolved in 150 gl of distilled water for ligand and immunoblot 
entiation and matrix production of osteoblasts [1,2]. IGFs can analysis and for IGF I radioimmunoassay. 
reach the bone compartment via the blood stream, and they 15-gl aliquots were electrophoresed on 15% sodium dodecyl sulfate 
(SDS) polyacrylamide g ls under nonreducing conditions (except 14C- 
are also synthesized locally. Besides IGF receptors, osteo- labeled molecular weight marker; Rainbow marker, Amersham, UK) 
blasts express IGFs and IGFBPs [3]. and transferred to nitrocellulose. The air-dried filters were washed in 
Cultured rat osteoblasts produce mainly IGF  I [4] and re- Tris-buffered saline (TBS; 0.15 M NaC1 and 0.01 M Tris, pH 7.4) 
lease IGFBP-2 and IGFBP-3 into the medium [5,6]. IGFBP-5 containing 0.1% Tween 20 and then incubated with 125I-labeled IGF 
II (4X 106 cpm per plastic bag) for 6 h at room temperature. After 
was discovered in the supernatant of human osteosarcoma washing with TBS containing 0.1% Tween 20, the filters were exposed 
cells [7] and in extracts of human bone [8], and was found for 1-2 days at -80°C to an X-ray film (Kodak X-Omat AR) in 
to stimulate DNA synthesis in mouse osteoblastic ells [7-9]. cassettes equipped with intensifying screens as described [6]. 
IGF I, prostaglandin E2, and parathyroid hormone increase For irrmaunoblot analysis 30-gl aliquots were loaded per lane. The 
IGFBP-5 mRNA in cultured perinatal rat calvaria-derived air-dried filters were washed in TBS pH 7.6 containing 0.1% Tween 
20. The first antibody (anti-IGFBP-5) was used at a dilution of 
cells [6,10]. In contrast o IGFBP-3, IGFBP-5 is preferentially 1:1000, the second (anti-guinea pig, horse-radish peroxidase-conju- 
bound to extracellular matrix in human fibroblast cultures gated, from Anawa, Wangen, Switzerland) at a dilution of 1:500. 
[11]. Intact IGFBP-5 associates with mouse bone matrix [12]. Bands were detected by enhanced chemiluminescence with RPN 
We have studied the effects of 1,25(OH)2D3 and compared 2106 following the prescription of the supplier (Amersham, UK). 
IGF I was extracted by Sep-Pak C18 cartridges and determined 
it with the effect of PTH on IGFBP-5 mRNA and on IGFBP- using rabbit antiserum (1:20000) against human IGF I and pure rat 
5 in the conditioned culture medium and the cell layer of rat IGF I (gift from Dr. Kobayashi, Fujisawa, Japan) as a standard [6]. 
osteoblast cultures because calcium-regulating hormones may 
use IGF to mediate part of their effects on bone turnover. 2.4. Processing of cell layers for analysis of lGFBPs 
For analysis of cell layer-associated IGFBPs, 1 ml of the Tris and 
2. Materials and methods SDS components of Laemmli buffer were added directly to the tissue 
culture plate and the material collected for subsequent SDS-PAGE 
2.1. Reagents (final concentrations for loading: 0.1 M Tris, pH 6.8, 2% SDS, 20% 
lc~,25-Dihydroxyvitamin D 3(1,25(OH)2D3), lct-hydroxyvitamin D3 glycerol). 15-gl aliquots were used for 125I-IGF II ligand blot and 30- 
(10~(OH)D3), 25-hydroxyvitamin Da (25(OH)D3), and 24R,25-dihy- ~tl aliquots for immunoblot analysis as described above. 
droxyvitamin D3 (24R,25(OH)2D3) were kindly provided by Dr. 
U. Fischer, Hoffmann-La Roche, Basel, Switzerland. Bovine 2.5. Extraction of total RATA and Northern analysis 
PTH(1-34) was from Bachem, Torrence, CA. Bovine serum albumin For RNA analysis, cells were rinsed with ice-cold PBS and lysed in 
guanidinium isothiocyanate for preparation of total RNA and North- 
ern analysis [6]. Human IGFBP-5 cDNA [14] was used for IGFBP-5 
hybridization and rat cDNAs for hybridization with IGF I and ~- 
*Corresponding author. Fax: (41) (1) 255 44 47. tubulin mRNA [6]. 
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3. Results A 
10 , ~  
3.1. IGFBP-5  mRNA expression ,.'" 
IGFBP-5 mRNA was detected as a single 6.5 kb transcript s T "'" 
by Northern blot analysis (Fig. 1). The relative abundance of z < ...Y"" 
IGFBP-5 mRNA was markedly increased in cells exposed to n, 
E 6 /'" 
1,25(OH)2D3 (Figs. 1 and 2) and PTH (Fig. 2). Both, ~ /" 
l '25(OH)2D3andPTHwereef fec t iveatac°ncent ra t i °n° f  m ~ ~ ~ t _ _  ~ ' ~  4 •'"' 
10 -11 moll1; 1,25(OH)2D3 was maximally effective at 10 .9 
moll1 and PTH at 10 -s mol/l (Fig. 2A). The vitamin D ana- 
logues lc~(OH)D3, 25(OH)D3, and 24R,25(OH)2D3 were also 2 
tested at different concentrations and found to be less potent *"~ 
i i i t J i than 1,25(OH)2D3 by two or more orders of magnitude (not o o o.ol o.1 1 lo loo 
shown). Time course experiments showed that 1,25(OH)2D3, concentration (nmol/I) 
in contrast to PTH, had no significant effect on IGFBP-5 
mRNA during the first 6 h. Stimulation plateaued at 24 h 
and persisted over 48 h, in contrast o that of PTH (Fig. 2B). B 10 .3~ 
3.2. IGFBP-5  in medium and cell layers 8 "" 
As assessed by ligand blot analysis, 42145/49 kDa IGFBPs, ,."" """ 
formerly identified as glycosylated forms of IGFBP-3 [15], and < /'" "'" ", 
z 6 T .  m " '" 31132 kDa IGFBPs accumulated in the conditioned medium n, .."" . 
(Fig. 3, upper left panel) [6]. A 32 kDa form has previously E f ] ", to "'. 
been identified as IGFBP-2 [5]. There is a little association of d 4 ~ _z_ 
42-49 kDa IGFBP-3 with the cell layer, but significant u. 
2 
1 ,25(OH)2D3,  mo l / !  
0 , , i , , I , , I , , I , I , J , i , i , , 
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10 "tt 10 "l° 10 .9 10 4 10 .7 time (h) 
Fig. 2. Effects of 1,25(OH)2D3 and PTH on IGFBP-5 mRNA levels 
in rat osteoblasts. (A) Dose dependence. Cells were grown as de- 
scribed and exposed to 1,25(OH)2D3 or PTH for 24 h. RNA was 
prepared and hybridized to cDNAs specific for IGFBP-5 and [3-tu- 
bulin mRNA. IGFBP-5 mRNA levels are expressed as ratio of opti- 
cal densities of hormone-treated to vehicle-treated cultures, corrected 
for optical densities of 13-tubulin mRNA signal on the same blot 
(ratio of optical density of IGFBP-5 mRNA to optical density of ~- 
tubulin mRNA in control cultures is defined as 1). Values represent 
the mean+S.D, of 4 experiments. 1,25(OH)2D3 (H) ;  PTH 
(O- - -  O). (B) Time course. Cells were exposed to 5 nM 
1,25(OH)2Da or 5 nM PTH, and RNA prepared after 2, 6, 24, and 
48 h was analyzed for the relative abundance of IGFBP-5 and 13-tu- 
bulin mRNA. For each time point, the optical density of IGFBP-5 
mRNA divided by the optical density of [3-tubulin mRNA of the 
control (vehicle-treated sample) was defined as 1. Mean va- 
lues+S.D, are given; n=3 for time points 2, 6, 24 h, and n=2 for 
48 h. 1,25(OH)2Da ( H ) ;  PTH (o - - - o). 
amounts of 31/32 kDa IGFBPs are attached to it (Fig. 3, 
upper right panel). According to the ligand blot analysis, 
1,25(OH)2D3 did not affect the release of IGFBPs into the 
medium. Intact IGFBP-5 was not detected in the medium 
by immunoblot (Fig. 3, lower left panel). A 31 kDa band 
detected by 125I-IGF II ligand blot and IGFBP-5 immunoblot 
analysis was more prominent in the cell layer lysate of 
1,25(OH)2D3- and of PTH-treated than of control osteo- 
blasts (Fig. 3, lower right panel), suggesting that this form 
Fig. 1. IGFBP-5 mRNA in rat osteoblasts exposed to 1,25(OH)2D3 corresponds to IGFBP-5. 
for 24 h. Cells were exposed to test media and 1,25(OH)2Dz as indi- 
cated, and RNA was prepared after 24 h. 20 gg of total RNA was 
subjected to Northern analysis. The autoradiograph of the blot after 3.3. IGF  ! production 
hybridization to cDNA specific for IGFBP-5 is shown. As evaluated by densitometry ([3-tubulin mRNA-corrected), 
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medium cell layer IGF I stimulates IGFBP-5 mRNA [6,10]. Both IGF I in the 
kDa M C a ka. C D V C D V culture medium and IGFBP-5 mRNAincrease with time after 
. . . . . . . . .  the preceding medium change in control cells [6]. Therefore, 
46 46 
this increase may be due to stimulation of IGFBP-5 mRNA 
• expression by auto/paracrine IGF I. By contrast, IGFBP-3 
~ ~ 3o mRNA does not markedly change with time after medium 
~ change, and IGF I does not increase IGFBP-3 mRNA [6]. 
~l.s ~l.s PTH does not enhance IGFBP-5 mRNA in normal mouse 
calvariae [12] but is a potent stimulator in normal rat osteo- 
14.3 14~ blasts (Fig. 2). It stimulates IGF I mRNA and IGF I release 
[6] more rapidly than IGFBP-5 mRNA. Therefore, auto/para- 
medium cell layer crine IGF I may mediate at least part of the stimulatory 
kDa M C D kDa C D P C D P 
B effects of PTH on IGFBP-5 mRNA expression. Furthermore, 
, ~ stimulatory effects of 1,25(OH)2D3 and PTH were different in !3o ~ course (Fig. 2B) (not shown). 30 time and additive 
| Intact IGFBP-5 does not accumulate in the medium of rat 
. . . .  | 21.s j 21.s osteoblasts but can be identified in the cell layer (Fig. 3). In 
contrast o IGFBP-3, IGFBP-5 is rapidly degraded in the 
J4.3 . . . . . .  ~3 medium but remains intact when associated with the cell layer 
Fig. 3. IGFBPs in serum-free culture media (supernatants, left pa- (Fig. 3) [17]. 
nels) and in cell layers (lysates, right panels) of cultured rat os teo -  IGFBP-5 is unique among the IGFBPs because it binds 
blasts exposed to test media for 24 h. Upper panels show ligand with high affinity and capacity to the extracellular matrix 
blots and lower panels immunoblots. Cells were handled and ex- 
posed to 10 ml test medium containing 5 nM 1,25(OH)2D3 or PTH produced by normal osteoblasts [8,12,17]. It is retained in 
for 24 h as described in Section 2. The medium was removed, dia- the bone compartment and thus may serve to trap IGFs with- 
lyzed, lyophilized and reconstituted in 150 ~tl H20. 15 ~tl (i.e. one in bone. Regulated local production and proteolytic leavage 
tenth of the material) was used for 12~I-IGF II ligand blot analysis of IGFBP-5 [17] may allow tight local control of IGF bioa- 
(upper left) and 30 ~tl (i.e. one fifth of the material) for IGFBP-5 vailability in bone. The fact that IGFBP-5 mRNA is upregu- 
immunoblot analysis (lower left). After washing, cell layers were 
lysed into 1 ml and 15 /al (i.e. 1.5% of the material) was used for lated by the osteotropic (resorption-stimulating) hormones 
125I-IGF II ligand blot (upper ight) and 30 ~tl (i.e. 3% of the mate- PTH and 1,25(OH)2D3 fits the hypothesis according to which 
rial) for immunoblot analysis (lower right). IGFBP-5 may help IGFs to serve as factors responsible for 
coupling bone formation to preceding resorption in vivo. 
IGF I mRNA levels were 1.5 (mean of 5 experiments; range 
0.9-1.9)-fold higher in 5 × 10 -9 mol/1 1,25(OH)2D3-treated Acknowledgements. Wethank Mrs. E. Futo and Mrs. C. Zwimpfer 
than in control cells. Analysis of media revealed slightly for performing IGF I radioimmunoassays, Mrs. Y. Glatz and Mrs. 
M. Waldvogel for ligand and immunoblot analysis, and Mrs. M. Sal- 
more IGF I in 5 × 10 -9 mol/1 1,25(OH)2D3-treated than in man for the preparation ofthe manuscript. This study was supported 
control cultures (range 3.8-15.0 ng/dish) during 24 h of incu- by grant No 32-31281.91 of the Swiss National Science Foundation. 
bation; in 5 independent experiments (duplicate dishes), stim- 
ulation was 1.4-fold (range 1.1-1.8-fold). 
References 
4. Discuss ion 
[1] Schmid, C., Steiner, T. and Froesch, E.R. (1984) FEBS Lett. 173, 
48-52. 
The human IGFBP-5 cDNA probe detected a single tran- [2] Hock, J.M., Centrella, M. and Canalis, E. (1988) Endocrinology 
script of 6.5 kb in RNA prepared from rat osteoblasts. The 122, 254-260. 
question whether 1,25(OH)2D3 regulates IGFBP-5 and IGF I [3] Jones, J.I. and Clemmons, D.R. (1995) Endocr. Rev. 16, 3-34. 
mRNA expression in normal osteoblasts has not been pre- [4] Schmid, Ch., Schl/ipfer, I., Keller, A., Waldvogel, M., Froesch, 
viously addressed in detail. As shown here, 1,25(OH)2D3 is E.R. and Zapf, J. (1995) Biochem. Biophys. Res. Commun. 212, 
242-248. 
a potent stimulator of IGFBP-5 mRNA. Its effect appears to [5] Schmid, Ch., Schliipfer, I., Waldvogel, M., Meier, P.J., Schwan- 
be more selective than that of PTH since 1,25(OH)2D3 does der, J. B6ni-Schnetzler, M., Zapf, J. and Froesch, E.R. (1992) 
not concomitantly stimulate mRNA [6] and release of IGFBP- FEBS Lett. 303, 205-209. 
3 (Fig. 3). In contrast o PTH, 1,25(OH)2D3 has very little [6] Schmid, C., Schl/ipfer, I., Peter, M., B6ni-Schnetzler, M., 
Schwander, J. Zapf, J. and Froesch, E.R. (1994) Am. J. Physiol. 
effect on IGF I mRNA; similarly, the stimulatory effect of 267, E226-E233. 
1,25(OH)2D3 on net release of immunoreactive IGF I into the [7] Andress, D.L. and R.S. Birnbaum (1991) Biochem. Biophys. Res. 
medium is minor, as previously reported in studies using fetal Commun. 176, 213-218. 
rat osteoblasts [16]. Therefore, it is unlikely that IGF I med- [8] Bautista, C.M., Baylink, D.J. and Mohan, S. (1991) Biochem. 
iates the stimulatory effect of 1,25(OH)2Da on IGFBP-5 Biophys. Res. Commun. 176, 756-763. 
mRNA. Moreover, the effects 1,25(OH)2D3 and IGF I on [9] Andress, D.L. and Birnbaum, R.S. (1992) J. Biol. Chem. 267, 
22467-22472. 
IGFBP-5 mRNA are additive (not shown). Finally, the stimu- [10] McCarthy, T.L., Casinghino, S., Centrella, M. and Canalis, E. 
latory effect of 1,25(OH)2D3, the biologically active metabo- (1994) J. Cell. Physiol. 160, 163-175. 
lite of vitamin D3, on IGFBP-5 mRNA seems to be specific [11] Jones, J.I., Gockerman, A., Busby, W.H., Camacho-Hubner, C. 
and Clemmons, D.R. (1993) J. Cell. Biol. 121, 679-687. 
because the vitamin D3 analogues were much less potent in [12] Hakeda, Y., Kawaguchi, H., Hurley, M., Pilbeam, C.C., Abreu, 
stimulating IGFBP-5 mRNA (not shown), consistent with C., Linkhart, T., Mohan, S., Kumegawa, M. and Raisz, L.G. 
their lower affinities for vitamin D receptors. (1996) J. Cell. Physiol. 166, 370-379. 
24 C Sehmid et al./FEBS Letters 392 (1996) 21-24 
[13] Backlejaw, P.F., Dai, Z., Clemmons, D.R. and D'Ercole, A.J. [16] Chen, T.L., Mallory, B. and Hintz, R.L. (1991) Calcif. Tissue Int. 
(1993) Endocrinology 132, 1677 1681. 48, 278-282. 
[14] Kiefer, M.C., Ioh, R.S., Bauer, D.M. and Zapf, J. (1991) Bio- [17] Schmid, Ch., Schl~ipfer, I., Froesch, E.R., Waldvogel, M. and 
chem. Biophys. Res. Commun. 176, 219-225. Zapf, J. (1995) Calcif. Tissue Int. 56, 460, A151. 
[15] Zapf, J., Born, W., Chang, J.-Y., James, P., Froesch, E.R. and 
Fischer, J.A. (1988) Biochem. Biophys. Res. Commun. 156, 
1187-1194. 
